DUBLIN--(BUSINESS WIRE)--The "Bioresorbable Coronary Stents Market Analysis By Brand Outlook (Absorb BVS, Absorb 2nd Generation, Magmaris, Magnitude, MeRes-100, DESolve), By Region, And Segment Forecasts, 2016 - 2025" report has been added to ResearchAndMarkets.com's offering.
Anticipated as well as recently launched global bioresorbable coronary stents market will trigger a revenue increase to USD 247 million by 2025
According to a new report by The report, Inc., better device attributes of second-generation coronary stents will provide the ascending push to this market.
Bioresorbable stents are intended majorly for the young adult population, whereby these individuals are enabled with a normal functioning artery following complete resorption of the dissolvable devices. Lifestyle diseases and prevalence of associated risk factors underpin the growth in atherosclerosis-related cardiac events. This drives the global disease prevalence in young adults as well as the high volume of elective Percutaneous Coronary Interventions (PCI).
What sets the second-generation bioresorbable coronary stents apart? - Learning from past mistakes, manufacturers have developed new generation bioresorbable with thinner strut thicknesses, faster resorption times, and better radial force. Amaranth, with a single-minded focus on strut thickness, has developed three such devices. Each with a thinner strut. The latest, Magnitude boasts of 100 microns.
Another factor providing a fillip to this market is the less-invasive nature of PCIs as compared to coronary artery bypass grafting, resulting in their high elective procedure volume. In most parts of the world, lack of auditing to check inappropriate surgeries drives the number of coronary stenting procedures. Hence, this market is expected to witness growth due to the high volume of elective PCI, particularly in APAC and Europe.
Key Topics Covered:
Chapter 1. Methodology & Scope
Chapter 2 Executive Summary
Chapter 3 Bioresorbable Coronary Stents Market Variables, Trends & Scope
Chapter 4 Bioresorbable Coronary Stents Market: Brand Outlook, Estimates & Trend Analysis
Chapter 5 Bioresorbable Coronary Stents Market: Regional Estimates & Trend Analysis
Chapter 6 Competitive Landscape
Chapter 7 Clinical Pipeline Overview
- Meril Lifesciences Pvt. Ltd.
- Elixir Medical Corporation
- REVA Medical
- Arterial Remodeling Technologies
For more information about this report visit https://www.researchandmarkets.com/research/6d8tvh/global?w=4